You just read:

Portola Pharmaceuticals Announces Data Presentations Highlighting Syk/JAK Inhibitor Clinical Development Program at 52nd American Society of Hematology Annual Meeting

News provided by

Portola Pharmaceuticals, Inc.

Dec 04, 2010, 10:17 ET